Clinical Trial Update: Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety, tolerability, immune response, and clinical activity of a booster immunization with AFFITOPE AD02 in Alzheimer's disease;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AFFITOPE AD02 (AD02)

Snippet

Sponsor: Affiris AG | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED